粪便提取系统市场Share, Size, Trends, Industry Analysis Report, By Assay (Calprotectin, Albumin, Hemoglobin, Bile Acids, Others); By Indication; By Analysis Test; By End Use; By Region; Segment Forecast, 2022 - 2030

报告摘要

2021年，全球粪便提取系统市场的价值为160亿美元，预计预测期内的CAGR 3.6％。粪便提取系统是一种用于收集粪便样本的装置/工具，用于检测粪便中存在的不同种类的病毒，细菌或任何其他类型的寄生粒子。

了解有关此报告的更多信息：request for sample pages

The positive identification of any parasite in the stool shows the presence of an infection in the patient’s body. The increasing prevalence of IBD (Inflammatory Bowel Diseases) is anticipated to boost the growth of the faecal extraction systems market. According to CDC (Center for Diseases Control & Prevention), there was an increase in the hospitalization rate of patients with IBD in the US, from 44.2% in 2001 to 59.7% in 2018, as over 3 million individuals have been affected by this disease.

However, the high cost of the product is anticipated to hinder the growth of the faecal extraction systems market. The onset of the COVID-19 reflects the downfall of the stool extraction systems market growth owing to the unprecedented restrictions on movement along with the disruptions in personal and business activities. The disruption in the supply chain, lockdown measures, and limited consumer spending is anticipated to hamper the faecal extraction systems industry growth.

The impact of the COVID-19 outbreak is far-reaching, having negative effects on individuals, communities, and societies across the globe. People suffering from chronic health conditions are more at risk of contracting and experiencing complications from COVID-19. The growing investments towards the development of a vaccine for COVID-19, along with the increasing spending towards patient treatment, are projected to hinder the investments towards the faecal extraction systems market.

Due to the outbreak, research and academic institutions have delayed or halted their research activities in this field. Further, the decline in corporate spending and government support is anticipated to hinder the growth of the stool extraction systems industry over the coming years. However, the faecal extraction systems market is anticipated to recover at a fast rate post-COVID.

Industry Dynamics

Growth Drivers
The primary factor responsible for the growth of the industry is the increasing prevalence of IBD. Additionally, the faecal samples obtained by the extraction systems help identify intestinal infections and other diseases that result in poor nutrient absorption. The proper use of a faecal extraction systems assists in reducing the need for other related diagnostic tests that are inconvenient & time-consuming.

预计这些因素会显着推动粪便提取系统行业的增长。此外，根据澳大利亚关键护理期刊2021，无突出相关性皮炎与粪便提取系统之间存在连接，该粪便提取系统与低负压抽吸设备相连。具有低负压抽吸的肛门袋是收集来自严重生病的粪便尿失禁的粪便样本有效。

预计这项研究可以帮助未来发展更好的粪便收集方法，从而降低收集后皮肤炎症和整体疼痛的危险。粪便收集系统和IAD（尿失禁相关皮炎）之间的这种联系预计会提供利润丰厚的粪便提取系统行业增长机会。此外，由于粪便样品可以从几个角度检查粪便样品，包括微生物，微观和其他样品，因此单个样品的各种应用推动产业生长。

报告细分

该市场主要基于测定，指示，分析试验，最终用途和地区进行分段。

通过测定	通过指示	通过分析测试	通过最终使用	按地区
Calprotectin Albumin Haemoglobin 胆汁酸 Others	Parasitic Infection 病毒感染 Bacterial Indication Poor Nutrient Absorption	Microscopic 化学 Immunological Microbiological	诊断中心 医院和诊所 Ambulatory Clinics 研究Centers	北美（美国，加拿大） 欧洲（法国，德国，英国，意大利，西班牙，荷兰，奥地利） Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) 拉丁美洲（巴西，墨西哥，阿根廷） 中东和非洲（沙特阿拉伯，阿联酋，以色列，南非）

了解有关此报告的更多信息：request for sample pages

分析洞察力

The Calprotectin segment is recorded to hold the larger shares in 2020 and is expected to lead the market in the forecasting years. The huge share of the segment can be attributed to the increasing number of IBD globally. According to the Morbidity and Mortality Report 2021, the prevalence of IBD in older adults has increased significantly over the past decade.

From 2001 to 2019, the number of Crohn’s disease cases increased by 3.4%, while ulcerative colitis increased by 2.8% annually. Ulcerative colitis and Crohn’s disease come under the gambit of IBS (Inflammatory Bowel Syndrome). The changes in the Calprotectin levels in the sample helps in identifying the disease that might be causing the problem.

The hemoglobin segment is projected to witness the highest growth rate in the forecasting years. The growth of the segment can be attributed to the rising prevalence of SBD (Significant Bowel Diseases) such as CRC (Colorectal Cancer), HRA (Higher Risk adenoma), and IBD. The results with f-Hb >10 microgram Hb/g faeces are defined as positive. Further, the hemoglobin test helps to guide the investigation in patients with rectal bleeding and further enables the doctor to take a better practical approach.

Geographic Overview

北美占2021年全球市场上最大的收入份额。北美市场的巨额份额可归因于关键市场参与者的存在，加上这些公司的最新发展数量的数量。例如，2018年3月，Werfen通过美国FDA（食品和药物管理局）对其专有的粪便提取系统进行了许可。

此外，Alpco是领先的粪便提取系统制造商之一，为其CalProtectin ELISA获得了美国FDA 510（K）间隙。这些发展，如这些展示了政府机构为开发新颖系统提供的鼓励，实现了市场的增长。此外，预计欧洲排水瓶市场将在预测年份上表现出最高的复合体。预计上升的研发活动将提高大便提取系统市场的增长。群众在群众的产品测试中越来越越来越多的新产品的研究是欧洲的崛起。

例如，Buehlmann与Telia（电子卫生平台的开发人员）合作，为IBD开发了一个远程医疗系统。提供服务，如全面的必威开户注册IBD患者监控，与医疗专业人士连续沟通，为他们提供他们的测试和其他人的状态。betway体育亚洲版入口预计这些技术的发展可能会推动市场的增长。

竞争洞察力

一些主要的players operating in the global market include ALPCO, Alpha Laboratories, Arbor Assays, bioMérieux, BÜHLMANN, Calpro AS (Svar Lifescience), Cancax Biotech, DRG INSTRUMENTS GMBH, Promega Corporation, and Werfen.

Faecal Extraction SystemsMarket Report Scope

报告属性	细节
2021年市场尺寸值	1.60亿美元
Revenue forecast in 2030	USD 2.19 billion
CAGR	从2022 - 2030年3.6％
Base year	20.21
Historical data	20.18 - 2020
预测期	20.22- 2030
Quantitative units	收入超过百万美元和2022年至2030美元的CAGR
Segments covered	通过指示，通过分析测试，通过区域使用，按区域
Regional scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Key companies	ALPCO, Alpha Laboratories, Arbor Assays, bioMérieux, BÜHLMANN, Calpro AS (Svar Lifescience), Cancax Biotech, DRG INSTRUMENTS GMBH, Promega Corporation, and Werfen.